Literature DB >> 9043818

Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization.

N Ogata1, C Yamamoto, M Miyashiro, H Yamada, M Matsushima, M Uyama.   

Abstract

PURPOSE: Transforming growth factor beta (TGF-beta) is a multifunctional cytokine that modulates biological events as diverse as wound healing and angiogenesis and which may be important in the pathogenesis of choroidal neovascularization. We investigated the mRNA expression of TGF-beta isoforms in a model of experimental choroidal neovascularization induced by krypton-laser photocoagulation.
METHODS: Rat TGF-beta 1, mouse TGF-beta 2 or TGF-beta 3 cDNAs was inserted into the pBluescript vector to prepare antisense and sense riboprobes. Intense laser burns were applied to the posterior poles of the eyes of pigmented rats according to a protocol described for producing choroidal neovascularization in these animals. At intervals up to 4 weeks after photocoagulation, the eyes were obtained and cut into thin sections. The sections were subjected to in situ hybridization with digoxigenin (DIG)-labeled single-strand riboprobes synthesized from each TGF-beta cDNA.
RESULTS: In normal adult rat retinas and choroids, TGF-beta 1 mRNA was found only in cells of the ganglion cell layer, TGF-beta 2 mRNA was found in cells of the ganglion cell layer and choriocapillaris endothelium, whereas TGF-beta 3 mRNA was not detected at all. During the process of neovascularization, TGF-beta 1 and TGF-beta 2 mRNAs (the latter being expressed more prominently) were detected in retinal pigment epithelial cells, fibroblast-like cells and the endothelium of the neovascular region. TGF-beta 2 was the predominant isoform of TGF-beta, and its expression was especially strong in the endothelium of the choroidal neovascularization at 2 weeks. However, TGF-beta mRNAs was decreased in cells 4 weeks after photocoagulation.
CONCLUSIONS: Our findings suggest that TGF-beta may act in the retina as a neurotrophic agent, since TGF-beta 1 is normally transcribed in ganglion cells and TGF-beta 2 is also transcribed in ganglion cells and choriocapillaris endothelium. TGF-beta 1 and TGF-beta 2 mRNA expression were increased in photocoagulated lesions from 3 days to 2 weeks after laser treatment. Therefore, it is likely that TGF-beta acts as a mediator of the neovascularization process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043818     DOI: 10.1076/ceyr.16.1.9.5121

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  22 in total

1.  Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model.

Authors:  Han Zhang; Zhe-Li Liu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 2.  Molecular pathology of age-related macular degeneration.

Authors:  Xiaoyan Ding; Mrinali Patel; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2008-11-06       Impact factor: 21.198

3.  Inhibitory effects of arresten on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 activation in mouse retinal endothelial cells.

Authors:  Chandra Shekar Boosani; Narasimharao Nalabothula; Nader Sheibani; Akulapalli Sudhakar
Journal:  Curr Eye Res       Date:  2010-01       Impact factor: 2.424

4.  An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.

Authors:  J Lahdenranta; R Pasqualini; R O Schlingemann; M Hagedorn; W B Stallcup; C D Bucana; R L Sidman; W Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

5.  TGF-β1 enhances SDF-1-induced migration and tube formation of choroid-retinal endothelial cells by up-regulating CXCR4 and CXCR7 expression.

Authors:  Yi-fan Feng; Fei Yuan; Hua Guo; Wei-zhong Wu
Journal:  Mol Cell Biochem       Date:  2014-08-20       Impact factor: 3.396

6.  Microscopic mammalian retinal pigment epithelium lesions induce widespread proliferation with differences in magnitude between center and periphery.

Authors:  Peter Lundh von Leithner; Coziana Ciurtin; Glen Jeffery
Journal:  Mol Vis       Date:  2010-03-31       Impact factor: 2.367

Review 7.  Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors:  Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

8.  Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.

Authors:  Filip Roudnicky; Jitao David Zhang; Bo Kyoung Kim; Nikhil J Pandya; Yanjun Lan; Lisa Sach-Peltason; Heloise Ragelle; Pamela Strassburger; Sabine Gruener; Mirjana Lazendic; Sabine Uhles; Franco Revelant; Oliv Eidam; Gregor Sturm; Verena Kueppers; Klaus Christensen; Leonard D Goldstein; Manuel Tzouros; Balazs Banfai; Zora Modrusan; Martin Graf; Christoph Patsch; Mark Burcin; Claas A Meyer; Peter D Westenskow; Chad A Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-05       Impact factor: 11.205

9.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

10.  Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants.

Authors:  T A Ciulla; M H Criswell; R P Danis; M Fronheiser; P Yuan; T A Cox; K G Csaky; M R Robinson
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.